Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Key, S. Scott, D. Davies, C. Warburton, J. Earis, P. Calverley (Liverpool, Salford, United Kingdom). The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease. Eur Respir J 2007; 30: Suppl. 51, 4492

Member's Comments

No comment yet.

Related content which might interest you: Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Exhaled nitric oxide as a biomarker in different COPD phenotypes Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003 Nitric oxide (NO) in exhaled breath helps to distinguish the origin of lung infiltrate Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Extended measurement of exhaled nitric oxide in patients after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 705s Year: 2005 Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Increased exhaled nitric oxide precedes lung fibrosis in a murine model of systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006 Value of exhaled nitric oxide in the evaluation of disease activity in sarcoidosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002 Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Increased alveolar concentrations of exhaled nitric oxide (NO) are associated with lung affection in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 543s Year: 2005 Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients? Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017